Medication leaflets

Active substance

Results for the substance teduglutide

3 results

About this active substance

Teduglutide is a medication used for the treatment of short bowel syndrome (SBS), a rare condition in which the intestine cannot absorb enough nutrients from food due to the loss of a significant portion of the bowel. Teduglutide is an analog of glucagon-like peptide-2 (GLP-2), which stimulates the regeneration and growth of the intestinal lining, thereby improving nutrient absorption.

This medication is administered via subcutaneous injection, usually once daily, and is intended for patients who rely on parenteral nutrition or intravenous fluids to maintain their nutritional status. Teduglutide can significantly reduce the need for parenteral nutrition, improving patients' quality of life.

Common side effects include abdominal pain, nausea, bloating, injection site reactions, and respiratory infections. Regular monitoring of intestinal and liver function is required during treatment. Teduglutide is not recommended for patients with a high risk of gastrointestinal cancer.